Macular dystrophy refers to a cluster of genetic eye disorders impacting the macula, the central portion of the retina essential for sharp vision. Conditions like Stargardt disease and Best disease fall under this umbrella, progressively deteriorating the macula. Symptoms often surface during childhood or adolescence, including distorted vision, difficulty in low light, and impaired color perception. While a cure remains elusive, various management approaches exist, such as utilizing low-vision aids, undergoing genetic counseling, and exploring experimental treatments like gene therapy to mitigate progression and alleviate symptoms. Regular consultations with an ophthalmologist are vital to monitor changes and optimize strategies for maintaining visual function.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom